Inactivation of the Tuberous Sclerosis Complex-1 and -2 Gene Products Occurs by Phosphoinositide 3-Kinase/Akt-dependent and -independent Phosphorylation of Tuberin
Open Access
- 1 September 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (39) , 37288-37296
- https://doi.org/10.1074/jbc.m303257200
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Tuberous sclerosis complex tumor suppressor–mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independentThe Journal of cell biology, 2002
- Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signalingProceedings of the National Academy of Sciences, 2002
- TSC1–TSC2: a complex tale of PKB-mediated S6K regulationNature Cell Biology, 2002
- Tsc tumour suppressor proteins antagonize amino-acid–TOR signallingNature Cell Biology, 2002
- Akt regulates growth by directly phosphorylating Tsc2Nature Cell Biology, 2002
- TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signallingNature Cell Biology, 2002
- TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growthGenes & Development, 2001
- Tsc2+/– mice develop tumors in multiple sites that express gelsolin and are influenced by genetic backgroundJournal of Clinical Investigation, 1999
- Role of Phosphatidylinositol-3-Kinase in Insulin Receptor Signaling: Studies with Inhibitor, LY294002Biochemical and Biophysical Research Communications, 1994
- Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patientsNature Genetics, 1994